immune globulin intravenous (human) - stwk 10 % per 50 ML Injection
- RxCUI
- 2672098
- RxNorm name
- immune globulin intravenous (human) - stwk 10 % per 50 ML Injection
- Display name
- immune globulin intravenous (human) - stwk 10 % per 50 ML Injection
- Full name
- immune globulin intravenous (human) - stwk 10 % per 50 ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:29
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125743 | Alyglo | immune globulin intravenous, human-stwk | 351(a) | Rx | 2026-09-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| fb97b3ec-29ee-4df1-aa99-c23e57a21228 | immune globulin intravenous (human) - stwk 10 % in 50 ML Injection [PSN] · 50 ML immune globulin intravenous (human) - stwk 100 MG/ML Injection [SCD] · immune globulin intravenous (human) - stwk 10 % per 50 ML Injection [SY] · immune globulin intravenous (human) - stwk 100 MG/ML per 50 ML Injection [SY] · immune globulin intravenous (human) - stwk 5 GM per 50 ML Injection [SY] | 5 | 4 | These highlights do not include all the information needed to use ALYGLO safely and effectively. See full prescribing information for ALYGLO . ALYGLO (immune globulin intravenous, human- stwk ) , 10% Liquid Initial U.S. Approval: 20 2 3 | 20250611 |